印度全国性的HPV疫苗接种运动于3月1日发起, 为近30万14岁女孩接种疫苗, 目的是消灭宫颈癌。 India's nationwide HPV vaccination campaign, launched March 1, has vaccinated nearly 300,000 girls aged 14, aiming to eliminate cervical cancer.

印度在3月1日启动的全国性HPV疫苗接种活动已经接种了近30万名14岁女孩,其中包括马德雅邦,安德拉邦,泰米尔纳德邦,古吉拉特邦,奥迪沙邦和米佐拉姆邦. A nationwide HPV vaccination campaign in India, launched on March 1, has vaccinated nearly 300,000 girls aged 14, with states including Madhya Pradesh, Andhra Pradesh, Tamil Nadu, Gujarat, Odisha, and Mizoram leading efforts. 单剂量疫苗对抗致癌的HPV菌株有效,可提供高达99%的保护,并已在全球使用25年以上,没有长期健康风险。 The single-dose vaccine, effective against cancer-causing HPV strains, offers up to 99% protection and has been used globally for over 25 years with no long-term health risks. 卫生官员和医学专家确认其安全性和有效性，驳斥网络上关于不孕不育及其副作用的错误信息。 Health officials and medical experts affirm its safety and efficacy, countering online misinformation about infertility and side effects. 该倡议由总理纳伦德拉·莫迪在阿杰默尔发起,旨在消除宫颈癌,并得到学校、社区和保健提供者的支持,预期在考试结束后疫苗接种将扩大。 The initiative, launched by Prime Minister Narendra Modi in Ajmer, aims to eliminate cervical cancer and is supported by schools, communities, and healthcare providers, with vaccination expected to expand after the exam period ends.